TITLE

COMMENTARY: Anidulafungin was noninferior to fluconazole for invasive candidiasis

AUTHOR(S)
Gea-Banacloche, Juan
PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on the study which examines the effect of anidulafungin and fluconazole in treating patients with candidemia or other forms of invasive candidiasis. According to the author, though fluconazole, amphotericin and echinocandins seem to have similar efficacy, choosing one over another should be based on specific characteristics of the patient and institution.
ACCESSION #
28694445

 

Related Articles

  • Anidulafungin was noninferior to fluconazole for invasive candidiasis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p15 

    The article presents a study which examines the effect of anidulafungin and fluconazole in treating patients with candidemia or other forms of invasive candidiasis. Here, the researchers use randomized, controlled, noninferiority trial. In patients with candidemia or invasive candidiasis, study...

  • Six Novel Antimycotics. Rubin, A.I.; Bagheri, B.; Scher, R.K. // American Journal of Clinical Dermatology;2002, Vol. 3 Issue 2, p71 

    We have reviewed six new antimycotic agents which have potential applications for human cutaneous and mucosal diseases. Information on these six drugs was obtained via an English language search of PubMed through the US National Library of Medicine. The antimycotic agents reviewed include...

  • Chloroquine diphosphate.  // Reactions Weekly;12/12/2009, Issue 1282, p16 

    The article describes the case of two elderly woman who acquired skin and mucosal pigmentation while undergoing chronic therapy with chloroquine diphosphate. The first patient, a 65-year-old woman, had blue-grey pigmentation on her skin, specifically on the right pretibia. The other patient also...

  • COMMENTARY: Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis. Shear, Neil H. // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14 

    The author comments on the study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. According to the author, the results in the study are not true for tinea corporis, hyperkeratoric tinea pedis, and foot onychomytosis, where oral antifungal...

  • Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p14 

    The article presents a study which examines the safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis. Here, the researcher use a randomized controlled trial. Study shows that oral antifungal therapy has low risk for adverse events in patients with superficial...

  • Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome. Thaler, Michael; Pastakia, Behram; Shawker, Thomas H.; O'Leary, Timothy; Pizzo, Philip A. // Annals of Internal Medicine;Jan88, Vol. 108 Issue 1, p88 

    Presents a study which examined the evolving nature of hepatosplenic candidiasis, focusing on diagnosis and treatment. Characteristics of focal hepatosplenic; Use of intensive chemotherapy; Reason for recommending the use of empirical anti-fungal therapy for high-risk patients; Description of...

  • Prophylactic Antifungal Therapy in the Intensive Care Unit. Rex, John H.; Sobel, Jack D. // Clinical Infectious Diseases;4/15/2001, Vol. 32 Issue 8, p1191 

    Examines the effectiveness of the use of antifungal prophylaxis in the prevention of candidal infections among intensive care unit (ICU) patients who do not have neutropenia. Factors which may contribute to the possibility of the use of prophylaxis; Relevance of prophylaxis to the population of...

  • Severe Candidal Infections. Edwards, John E.; Lehrer, Robert I.; Stiehm, E. Richard; Fischer, Thomas J.; Young, Lowell S. // Annals of Internal Medicine;Jul78, Vol. 89 Issue 1, p91 

    Provides information on candidal infections. Primary drugs for the treatment of disseminated candidiasis; Host defense mechanisms against disseminated candidiasis; Clinical aspects of chronic mucocutaneous candidiasis; Approaches in the immune therapy and antimycotic treatment of chronic...

  • Anidulafungin effective in treating candidaemia in selected intensive care unit patients.  // British Journal of Hospital Medicine (17508460);Feb2011, Vol. 72 Issue 2, p69 

    The article reports findings from the Invasive Candidiasis Intensive Care Study (ICE), carried out on patients with candidaemia or invasive candidiasis in the intensive care unit, which showed that anidulafungin was more effective than fluconazole in the treatment of candidaemia.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics